Economic costs associated with an MS relapse

Hdl Handle:
http://hdl.handle.net/10147/326361
Title:
Economic costs associated with an MS relapse
Authors:
O'Connell, K.; Kelly, S.B.; Fogarty, E.; Duggan, M.; Buckley, L.; Hutchinson, M.; McGuigan, C.; Tubridy, N.
Affiliation:
National Centre for Pharmacoeconomics, Dublin, Ireland.
Citation:
O'Connell K et al. Economic costs associated with an MS relapse. Multiple Sclerosis Rel Disord 2014 [published online 16 September 2014]
Publisher:
Multiple Sclerosis and Related Disorders
Journal:
Multiple Sclerosis and Related Disorders
Issue Date:
Sep-2014
URI:
http://hdl.handle.net/10147/326361
DOI:
10.1016/j.msard.2014.09.002
Additional Links:
http://linkinghub.elsevier.com/retrieve/pii/S2211034814001060
Abstract:
This was an prospective audit composed of medical chart review and patient questionnaire. Relapses were stratified into 3 groups: low, moderate and high intensity. Age, gender, MS subtype, disease duration, expanded disability status scale (EDSS) score, disease modifying therapy (DMT) use and employment status were recorded. Direct costs included GP visits, investigations, clinic visit, consultations with medical staff, medication and admission costs. Indirect costs assessed loss of earnings, partner's loss of earnings, childcare, meals and travel costs.
Item Type:
Article
Language:
en
Keywords:
MULTIPLE SCLEROSIS; ECONOMIC FACTOR
ISSN:
22110348

Full metadata record

DC FieldValue Language
dc.contributor.authorO'Connell, K.en_GB
dc.contributor.authorKelly, S.B.en_GB
dc.contributor.authorFogarty, E.en_GB
dc.contributor.authorDuggan, M.en_GB
dc.contributor.authorBuckley, L.en_GB
dc.contributor.authorHutchinson, M.en_GB
dc.contributor.authorMcGuigan, C.en_GB
dc.contributor.authorTubridy, N.en_GB
dc.date.accessioned2014-09-22T14:07:08Z-
dc.date.available2014-09-22T14:07:08Z-
dc.date.issued2014-09-
dc.identifier.citationO'Connell K et al. Economic costs associated with an MS relapse. Multiple Sclerosis Rel Disord 2014 [published online 16 September 2014]en_GB
dc.identifier.issn22110348-
dc.identifier.doi10.1016/j.msard.2014.09.002-
dc.identifier.urihttp://hdl.handle.net/10147/326361-
dc.description.abstractThis was an prospective audit composed of medical chart review and patient questionnaire. Relapses were stratified into 3 groups: low, moderate and high intensity. Age, gender, MS subtype, disease duration, expanded disability status scale (EDSS) score, disease modifying therapy (DMT) use and employment status were recorded. Direct costs included GP visits, investigations, clinic visit, consultations with medical staff, medication and admission costs. Indirect costs assessed loss of earnings, partner's loss of earnings, childcare, meals and travel costs.en_GB
dc.language.isoenen
dc.publisherMultiple Sclerosis and Related Disordersen_GB
dc.relation.urlhttp://linkinghub.elsevier.com/retrieve/pii/S2211034814001060en_GB
dc.rightsArchived with thanks to Multiple Sclerosis and Related Disordersen_GB
dc.subjectMULTIPLE SCLEROSISen_GB
dc.subjectECONOMIC FACTORen_GB
dc.titleEconomic costs associated with an MS relapseen_GB
dc.typeArticleen
dc.contributor.departmentNational Centre for Pharmacoeconomics, Dublin, Ireland.en_GB
dc.identifier.journalMultiple Sclerosis and Related Disordersen_GB
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.